Comments
Loading...

Capricor Therapeutics

CAPRNASDAQ
Logo brought to you by Benzinga Data
$5.10
-0.02-0.39%
Pre-Market: 6:50 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$40.00
Lowest Price Target1
$8.00
Consensus Price Target1
$20.00

Capricor Therapeutics (NASDAQ:CAPR) Stock, Analyst Ratings, Price Targets, Forecasts

Capricor Therapeutics Inc has a consensus price target of $20 based on the ratings of 5 analysts. The high is $40 issued by HC Wainwright & Co. on September 17, 2024. The low is $8 issued by Cantor Fitzgerald on May 14, 2024. The 3 most-recent analyst ratings were released by Oppenheimer, Maxim Group, and HC Wainwright & Co. on September 17, 2024, respectively. With an average price target of $22.33 between Oppenheimer, Maxim Group, and HC Wainwright & Co., there's an implied 337.91% upside for Capricor Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
2
May
0
0
0
0
Jul
1
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Oppenheimer
Maxim Group
HC Wainwright & Co.
Cantor Fitzgerald
Ladenburg Thalmann

1calculated from analyst ratings

Analyst Ratings for Capricor Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Capricor Therapeutics (CAPR) stock?

A

The latest price target for Capricor Therapeutics (NASDAQ:CAPR) was reported by Oppenheimer on September 17, 2024. The analyst firm set a price target for $15.00 expecting CAPR to rise to within 12 months (a possible 194.12% upside). 12 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Capricor Therapeutics (CAPR)?

A

The latest analyst rating for Capricor Therapeutics (NASDAQ:CAPR) was provided by Oppenheimer, and Capricor Therapeutics maintained their outperform rating.

Q

When was the last upgrade for Capricor Therapeutics (CAPR)?

A

There is no last upgrade for Capricor Therapeutics

Q

When was the last downgrade for Capricor Therapeutics (CAPR)?

A

There is no last downgrade for Capricor Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Capricor Therapeutics (CAPR)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Capricor Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Capricor Therapeutics was filed on September 17, 2024 so you should expect the next rating to be made available sometime around September 17, 2025.

Q

Is the Analyst Rating Capricor Therapeutics (CAPR) correct?

A

While ratings are subjective and will change, the latest Capricor Therapeutics (CAPR) rating was a maintained with a price target of $14.00 to $15.00. The current price Capricor Therapeutics (CAPR) is trading at is $5.10, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch